Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children

Includes abstract.

Saved in:
Bibliographic Details
Main Author: Amlabu, Veronica Asibi
Other Authors: McIlleron, Helen
Format: Thesis
Language:English
Published: Division of Clinical Pharmacology 2014
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867614462285971456
access_status_str Open Access
author Amlabu, Veronica Asibi
author2 McIlleron, Helen
author_browse Amlabu, Veronica Asibi
McIlleron, Helen
author_facet McIlleron, Helen
Amlabu, Veronica Asibi
author_sort Amlabu, Veronica Asibi
collection Thesis
description Includes abstract.
format Thesis
id oai:open.uct.ac.za:11427/3307
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:52:25.630Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2014
publishDateRange 2014
publishDateSort 2014
publisher Division of Clinical Pharmacology
publisherStr Division of Clinical Pharmacology
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/3307 Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children Amlabu, Veronica Asibi McIlleron, Helen Smith, Pete Pharmacology Includes abstract. Includes bibliographical references. The World Health Organization recommends the use of isoniazid preventive therapy to reduce the incidence of tuberculosis disease in populations at risk for developing the disease. Adherence to isoniazid preventive therapy is needful for efficacy. A urine assay known as the Arkansas test is widely used to monitor the ingestion of isoniazid. However, this test is limited by a drop in sensitivity with increasing time post isoniazid dose. Furthermore, results from the test can be affected by observer variation in colour changes, concomitant medications, urinary dilution, and presence of other substances in urine. Moreover, the Arkansas test results have not been evaluated against objective measurement of isoniazid and acetylisoniazid urine concentrations. This study seeks to measure the urine concentrations of isoniazid and acetylisoniazid at different time points after a dose in children, in order to establish reference ranges for liquid chromatography tandem mass spectrometry measurements of urine isoniazid and acetylisoniazid, as well as the Arkansas method. The reference ranges would provide a standard which can be used to estimate the probability of adherence to prior doses. 2014-07-28T18:21:09Z 2014-07-28T18:21:09Z 2013 Master Thesis Masters MMed http://hdl.handle.net/11427/3307 eng application/pdf Division of Clinical Pharmacology Faculty of Health Sciences University of Cape Town
spellingShingle Pharmacology
Amlabu, Veronica Asibi
Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
thesis_degree_str Master's
title Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
title_full Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
title_fullStr Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
title_full_unstemmed Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
title_short Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
title_sort isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
topic Pharmacology
url http://hdl.handle.net/11427/3307
work_keys_str_mv AT amlabuveronicaasibi isoniazidandacetylisoniazidurineconcentrationsasamakerofadherencetoisoniazidpreventativetherapyinchildren